Home › Type 2 Diabetes › Connecticut › Bridgeport
Type 2 Diabetes clinical trials in Bridgeport, CT
4 studies for Type 2 Diabetes are looking for participants at sites in and around Bridgeport (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Cardiology Physicians of Fairfield County - Bridgeport, Bridgeport
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
- New England Research Associates, LLC, Bridgeport
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, Bridgeport
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, Bridgeport
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL24 studies
- Boston, MA20 studies
- Miami, FL19 studies
- Chicago, IL19 studies
- Dallas, TX19 studies
- Columbus, OH18 studies
- Las Vegas, NV18 studies
- Atlanta, GA17 studies
- San Diego, CA17 studies
- Los Angeles, CA16 studies
Other studies in Bridgeport
- Breast Cancer21 studies
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer13 studies
- Acute Myeloid Leukemia12 studies
- Cardiovascular Disease9 studies
- Head and Neck Squamous Cell Carcinoma8 studies
- Cancer (all types)8 studies
- Metastatic Cancer7 studies
- Heart Failure7 studies
- Brain Aneurysm6 studies
- Prostate Cancer6 studies
- Multiple Myeloma6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.